These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28801223)

  • 1. Limited benefits of presymptomatic cord blood transplantation in neurovisceral acid sphingomyelinase deficiency (ASMD) intermediate type.
    Mercati O; Pichard S; Ouachée M; Froissart R; Fenneteau O; Roche B; Elmaleh-Bergès M; Bertrand Y; Ogier de Baulny H; Vanier MT; Schiff M
    Eur J Paediatr Neurol; 2017 Nov; 21(6):907-911. PubMed ID: 28801223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic visceral acid sphingomyelinase deficiency (Niemann-Pick disease type B) in 16 Polish patients: long-term follow-up.
    Lipiński P; Kuchar L; Zakharova EY; Baydakova GV; Ługowska A; Tylki-Szymańska A
    Orphanet J Rare Dis; 2019 Feb; 14(1):55. PubMed ID: 30795770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): Literature review and report of new cases.
    Cassiman D; Packman S; Bembi B; Turkia HB; Al-Sayed M; Schiff M; Imrie J; Mabe P; Takahashi T; Mengel KE; Giugliani R; Cox GF
    Mol Genet Metab; 2016 Jul; 118(3):206-213. PubMed ID: 27198631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease.
    Schuchman EH
    Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S48-57. PubMed ID: 20040312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acid sphingomyelinase deficiency (Niemann-Pick disease type B) in adulthood: A retrospective multicentric study of 28 adult cases].
    Lidove O; Belmatoug N; Froissart R; Lavigne C; Durieu I; Mazodier K; Serratrice C; Douillard C; Goizet C; Cathebras P; Besson G; Amoura Z; Tazi A; Gatfossé M; Rivière S; Sené T; Vanier MT; Ziza JM
    Rev Med Interne; 2017 May; 38(5):291-299. PubMed ID: 27884455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease.
    Miranda SR; Erlich S; Friedrich VL; Gatt S; Schuchman EH
    Gene Ther; 2000 Oct; 7(20):1768-76. PubMed ID: 11083499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of endpoints in clinical trials for acid sphingomyelinase deficiency enzyme replacement therapy.
    Jones SA; McGovern M; Lidove O; Giugliani R; Mistry PK; Dionisi-Vici C; Munoz-Rojas MV; Nalysnyk L; Schecter AD; Wasserstein M
    Mol Genet Metab; 2020; 131(1-2):116-123. PubMed ID: 32616389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid sphingomyelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study.
    Pavlů-Pereira H; Asfaw B; Poupctová H; Ledvinová J; Sikora J; Vanier MT; Sandhoff K; Zeman J; Novotná Z; Chudoba D; Elleder M
    J Inherit Metab Dis; 2005; 28(2):203-27. PubMed ID: 15877209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of SMPD1 mutations in Asian-Indian patients with acid sphingomyelinase (ASM)-deficient Niemann-Pick disease.
    Ranganath P; Matta D; Bhavani GS; Wangnekar S; Jain JM; Verma IC; Kabra M; Puri RD; Danda S; Gupta N; Girisha KM; Sankar VH; Patil SJ; Ramadevi AR; Bhat M; Gowrishankar K; Mandal K; Aggarwal S; Tamhankar PM; Tilak P; Phadke SR; Dalal A
    Am J Med Genet A; 2016 Oct; 170(10):2719-30. PubMed ID: 27338287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Early-Onset Neuronopathic Form of Acid Sphingomyelinase Deficiency: A SMPD1 p.C133Y Mutation in the Saposin Domain of Acid Sphingomyelinase.
    Ota S; Noguchi A; Kondo D; Nakajima Y; Ito T; Arai H; Takahashi T
    Tohoku J Exp Med; 2020 Jan; 250(1):5-11. PubMed ID: 31941852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann-Pick disease types A, B and A/B).
    Geberhiwot T; Wasserstein M; Wanninayake S; Bolton SC; Dardis A; Lehman A; Lidove O; Dawson C; Giugliani R; Imrie J; Hopkin J; Green J; de Vicente Corbeira D; Madathil S; Mengel E; Ezgü F; Pettazzoni M; Sjouke B; Hollak C; Vanier MT; McGovern M; Schuchman E
    Orphanet J Rare Dis; 2023 Apr; 18(1):85. PubMed ID: 37069638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations in the SMPD1 gene in Jordanian children with Acid sphingomyelinase deficiency (Niemann-Pick types A and B).
    Al-Eitan L; Alqa'qa' K; Amayreh W; Aljamal H; Khasawneh R; Al-Zoubi B; Okour I; Haddad A; Haddad Y; Haddad H
    Gene; 2020 Jul; 747():144683. PubMed ID: 32311413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous pArg610del Mutation Unusually Associated With Severe Delay of Growth in 2 Acid Sphingomyelinase Deficiency-affected Sibs.
    Naifar M; Kallel F; HadjKacem F; Boudabous H; Kallel R; Boudawara T; Messaoud O; Tbib N; Charfi N; Abid M; Froissart R; Messedi SH; Ayedi F
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):e499-e502. PubMed ID: 30870388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autopsy pathology of infantile neurovisceral ASMD (Niemann-Pick Disease type A): Clinicopathologic correlations of a case report.
    Thurberg BL
    Mol Genet Metab Rep; 2020 Sep; 24():100626. PubMed ID: 32714837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lysosomal sphingomyelinase deficiency: spectrum of phenotypes in Czech and Slovak patients].
    Elleder M; Poupĕtová H; Ledvinová J; Zeman J; Rosipal S; Kraus J
    Cas Lek Cesk; 2001 Dec; 140(24):755-60. PubMed ID: 14655278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly variable neural involvement in sphingomyelinase-deficient Niemann-Pick disease caused by an ancestral Gypsy mutation.
    Mihaylova V; Hantke J; Sinigerska I; Cherninkova S; Raicheva M; Bouwer S; Tincheva R; Khuyomdziev D; Bertranpetit J; Chandler D; Angelicheva D; Kremensky I; Seeman P; Tournev I; Kalaydjieva L
    Brain; 2007 Apr; 130(Pt 4):1050-61. PubMed ID: 17360762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD).
    Wasserstein M; Dionisi-Vici C; Giugliani R; Hwu WL; Lidove O; Lukacs Z; Mengel E; Mistry PK; Schuchman EH; McGovern M
    Mol Genet Metab; 2019 Feb; 126(2):98-105. PubMed ID: 30514648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease spectrum and natural course in attenuated patients.
    Hollak CE; de Sonnaville ES; Cassiman D; Linthorst GE; Groener JE; Morava E; Wevers RA; Mannens M; Aerts JM; Meersseman W; Akkerman E; Niezen-Koning KE; Mulder MF; Visser G; Wijburg FA; Lefeber D; Poorthuis BJ
    Mol Genet Metab; 2012 Nov; 107(3):526-33. PubMed ID: 22818240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niemann-Pick disease (variation in the sphingomyelinase deficient group). Neurovisceral phenotype (A) with an abnormally protracted clinical course and variable expression of neurological symptomatology in three siblings.
    Elleder M; Cihula J
    Eur J Pediatr; 1983 Sep; 140(4):323-8. PubMed ID: 6628453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease.
    Schuchman EH
    J Inherit Metab Dis; 2007 Oct; 30(5):654-63. PubMed ID: 17632693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.